Finance

Lists
Why is 1KJ up 15.89%?
Dive Deeper
1KJ:FRA
10X Genomics Inc
€73.96
+15.89%
(+10.14) 1D
Oct 9, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1KJ...
Open
€68.06
High
€73.96
Low
€68.06
Mkt. cap
10.51B
Avg. vol.
249.00
Volume
189.00
52-wk high
€91.10
52-wk low
€9.50
No. of employees
1K
Open
€68.06
High
€73.96
Low
€68.06
Mkt. cap
10.51B
Avg. vol.
249.00
Volume
189.00
52-wk high
€91.10
52-wk low
€9.50
No. of employees
1K
News stories
From web sources and news partners
Profile
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics. Wikipedia
About 10X Genomics Inc
CEOSerge Saxonov
Employees1.18K
Founded2012
HeadquartersPleasanton, California, United States
SectorHealth care
Website10xgenomics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
149.00M
166.03M
150.84M
151.04M
Cost of goods sold
48.70M
52.88M
44.66M
38.54M
Cost of revenue
48.70M
52.88M
44.66M
38.54M
Research and development expenses
57.19M
55.77M
56.85M
56.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
74.66M
73.02M
66.38M
78.66M
Operating expense
131.85M
128.79M
123.22M
135.45M
Total operating expenses
180.54M
181.67M
167.89M
173.99M
Operating income
-31.54M
-15.64M
-17.05M
-22.96M
Other non operating income
538.00K
-3.04M
-72.00K
-3.49M
EBT including unusual items
-28.20M
-15.19M
-12.85M
-18.64M
EBT excluding unusual items
-26.40M
-12.39M
-12.90M
-22.04M
Income tax expense
-733.00K
1.06M
623.00K
-714.00K
Effective tax rate
2.60%
-6.97%
-4.85%
3.83%
Other operating expenses
-
-
-
-
Net income
-27.47M
-16.25M
-13.47M
-17.93M
Net profit margin
-18.44%
-9.79%
-8.93%
-11.87%
Earnings per share
-0.02
0.07
0.07
0.03
Interest and investment income
5.20M
6.89M
5.01M
4.80M
Interest expense
-
-
-
-
Net interest expenses
5.20M
6.89M
5.01M
4.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.24M
-5.58M
-7.09M
-13.29M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps